Division of Vascular Surgery, Department of Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.
Eur J Vasc Endovasc Surg. 2010 Jun;39(6):731-7. doi: 10.1016/j.ejvs.2010.03.019. Epub 2010 Apr 28.
This article describes the long-term outcome of surgical treatment in children with renovascular hypertension (RVH) over a 40-year period.
Retrospective study.
Twenty-five consecutive patients, aged 5-21 years, underwent renal artery (RA) repair from 1967 to 1995. The disease consisted of fibromuscular dysplasia in 17 patients, Takayasu's arteritis in 7 and neurofibromatosis type 1 in one patient.
Twenty-nine RAs were repaired. Primary procedures included aortorenal bypass (ARB) with prosthesis in 10 RAs, autologous vein in five or internal iliac artery in four as conduits, direct reimplantation (DR) in four and nephrectomy in two RAs. Immediate graft failure occurred in three patients despite no peri-operative deaths. After a mean follow-up of 24.4 years, seven patients required secondary nephrectomy. Autologous ARB or DR showed better RA patency and fewer chances for secondary nephrectomy than prosthetic ARB. Hypertension was cured or improved in 21 patients. The overall cumulative survival rate at 20 years was 84%. All five deaths, observed a mean of 12.6 years after the initial operation, were attributed to cardiovascular events.
Surgical treatment, especially autologous ARB or DR, seems to provide durable results for paediatric RVH. Long-term observation and control of hypertension is mandatory.
本文描述了在 40 年的时间里,对患有肾血管性高血压(RVH)的儿童进行手术治疗的长期结果。
回顾性研究。
25 例连续患者,年龄 5-21 岁,于 1967 年至 1995 年期间接受了肾动脉(RA)修复。疾病包括 17 例纤维肌性发育不良、7 例 Takayasu 动脉炎和 1 例 1 型神经纤维瘤病。
修复了 29 个 RA。主要手术包括使用假体的主动脉-肾旁路(ARB)修复 10 个 RA,自体静脉修复 5 个,或内髂动脉修复 4 个作为移植物,直接再植入(DR)修复 4 个,RA 切除术修复 2 个。尽管没有围手术期死亡,但 3 例患者术后即刻发生移植物失败。平均随访 24.4 年后,7 例患者需要进行二次肾切除术。自体 ARB 或 DR 显示出更好的 RA 通畅性和较少需要二次肾切除术的机会,而非假体 ARB。21 例患者高血压得到治愈或改善。20 年的总体累积生存率为 84%。所有 5 例死亡均归因于心血管事件,观察时间平均为初始手术后 12.6 年。
手术治疗,特别是自体 ARB 或 DR,似乎为儿科 RVH 提供了持久的结果。必须进行长期观察和控制高血压。